Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Randomized, Double Blind, Placebo-Controlled, Parallel Group Study to Evaluate the Efficacy and Safety of Dupilumab in Patients With Persistent Asthma

NCT02414854 is registered in ClinicalTrials.gov with Sanofi as lead sponsor.

NCT NCT02414854
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02414854 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Randomized, Double Blind, Placebo-Controlled, Parallel Group Study to Evaluate the Efficacy and Safety of Dupilumab in Patients With Persistent Asthma
Lead sponsor
Sanofi
Phase
Phase 3
Overall status
Completed
Start date
April 27, 2015
Completion date
November 23, 2017
Enrollment
1,902 (actual)
Sites
389

Conditions

As the registry lists them; a condition with its own page is linked.

asthma